A detailed history of Fcf Advisors LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Fcf Advisors LLC holds 20,663 shares of MEDP stock, worth $12.2 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
20,663
Previous 16,746 23.39%
Holding current value
$12.2 Million
Previous $5.26 Million 102.17%
% of portfolio
1.47%
Previous 0.76%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$308.88 - $514.16 $1.21 Million - $2.01 Million
3,917 Added 23.39%
20,663 $10.6 Million
Q2 2025

Jul 11, 2025

BUY
$277.23 - $315.28 $79,565 - $90,485
287 Added 1.74%
16,746 $5.26 Million
Q1 2025

Apr 15, 2025

BUY
$304.69 - $360.97 $2.11 Million - $2.5 Million
6,931 Added 72.74%
16,459 $5.01 Million
Q4 2024

Feb 13, 2025

BUY
$308.93 - $363.58 $919,375 - $1.08 Million
2,976 Added 45.42%
9,528 $3.17 Million
Q3 2024

Oct 08, 2024

SELL
$320.58 - $457.29 $1.03 Million - $1.47 Million
-3,221 Reduced 32.96%
6,552 $2.19 Million
Q2 2024

Jul 18, 2024

BUY
$372.0 - $424.34 $1,488 - $1,697
4 Added 0.04%
9,773 $4.03 Million
Q1 2024

Apr 12, 2024

SELL
$284.87 - $413.31 $10,255 - $14,879
-36 Reduced 0.37%
9,769 $3.95 Million
Q4 2023

Jan 04, 2024

BUY
$227.52 - $312.68 $991,077 - $1.36 Million
4,356 Added 79.94%
9,805 $3.01 Million
Q3 2023

Oct 10, 2023

SELL
$233.98 - $281.67 $35,097 - $42,250
-150 Reduced 2.68%
5,449 $1.32 Million
Q2 2023

Jul 19, 2023

SELL
$187.26 - $240.17 $6,741 - $8,646
-36 Reduced 0.64%
5,599 $1.34 Million
Q1 2023

Apr 19, 2023

BUY
$174.31 - $239.52 $125,503 - $172,454
720 Added 14.65%
5,635 $1.06 Million
Q4 2022

Feb 03, 2023

SELL
$153.06 - $226.57 $16,530 - $24,469
-108 Reduced 2.15%
4,915 $1.04 Million
Q3 2022

Oct 12, 2022

BUY
$145.13 - $182.49 $728,987 - $916,647
5,023 New
5,023 $789,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $18.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Fcf Advisors LLC Portfolio

Follow Fcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.